Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV
Reviews in Medical Virology · 2025
DOI: 10.1002/rmv.70059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2025. Verfasst von Jeffrey V Lazarus und 4 weiteren Autor:innen. Beteiligte Einrichtung: CUNY Graduate School of Public Health and Health Policy, New York, New York, USA. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis C, Hepatitis B, Dried Blood Spot Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Approximately 3.5 million people acquired HBV, HCV, or HIV‐1 in 2022, and 340 million persons are infected with at least one of these three viruses, mostly in low‐ and middle‐income countries (LMICs). Nucleic acid amplification tests (NAAT) are precise and sensitive tools for viral infection diagnosis, monitoring and sequencing. NAATs typically rely on plasma specimens, which can be challenging to collect, store and transport in LMICs, limiting the reach of NAAT testing in rural and other resource constrained settings where trained phlebotomists and/or a cold chain for preservation and shipping are not available. Alternative specimen types that can overcome this limitation include dried blood spots (DBS) and dried plasma prepared using the Cobas Plasma Separation Card (PSC). We performed a literature review of DBS and PSC use for NAAT of HBV, HCV, or HIV‐1 to summarise their performance characteristics, relative advantages and disadvantages and potential to support expanded access to NAAT. DBS have been used extensively for HIV‐1 diagnosis and viral load monitoring, as well as for HBV and HCV, albeit to a much lesser degree. Compared to plasma, DBS perform well in terms of accuracy but have lower sensitivity. There is a risk of low specificity due to the presence of cellular nucleic acids in DBS and a resulting over‐estimation of viral load. The PSC has similar accuracy and sensitivity compared to DBS, but improved specificity due to the removal of cellular components. Both DBS and PSC have the potential to enhance access in populations where the use of plasma is challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- CUNY Graduate School of Public Health and Health Policy, New York, New York, USA.
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
- Data First Consulting, Sebastopol, California, USA.
- Doctor's Plaza, Clifton, Karachi, Pakistan.
- Roche Molecular Systems, Pleasanton, California, USA.
- Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, Georgia, USA.
ORCID-Profile: Neil Parkin
Zitieren
APA
Lazarus, J. V., Parkin, N., Qureshi, H., LaBrot, B., & Ward, J. W. (2025). Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70059
Vancouver
Lazarus JV, Parkin N, Qureshi H, LaBrot B, Ward JW. Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70059
BibTeX
@article{Lazarus2025,
author = {Lazarus, Jeffrey V and Parkin, Neil and Qureshi, Huma and LaBrot, Benjamin and Ward, John W},
title = {Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV},
journal = {Reviews in Medical Virology},
year = {2025},
doi = {10.1002/rmv.70059}
}
EUVIMED